Bio Break: How to Successfully Pivot in Medical Device Development
In the world of medical device development, unexpected challenges often lead to critical product pivots. In this episode of Bio Break, Nick and Joris discuss one of the most dramatic pivots they’ve encountered—transforming a lab-developed test (LDT) into a lateral flow assay to expand its market reach.
Initially, the client had a blood-based diagnostic test licensed for use in North America but wanted to serve global markets. Their original approach involved developing a blood spot sampling system, where patients would send dried blood samples by mail for lab analysis. However, after evaluating the logistics, the team proposed a game-changing pivot: converting the assay into a lateral flow test, making it more accessible and reducing the need for centralized lab processing.
This shift represented a major transformation—moving from a laboratory test requiring trained technicians to a rapid test that could be performed by users at home. This meant rethinking regulatory strategies, usability considerations, and product stability while maintaining diagnostic accuracy. The outcome? A scalable and commercially viable point-of-care diagnostic that opened new global opportunities for the company.
Pivoting in medical device innovation isn’t just about solving technical challenges—it’s about recognizing when to rethink market access, user needs, and business models. In this conversation, Nick and Joris highlight the key considerations when making strategic pivots and the lessons learned from adapting diagnostic technologies to new formats.
How to Successfully Pivot in Medical Device Development
Related Resources
Nick and Nigel explore the science behind hand sanitizer formulations. They discuss how alcohol interacts with bacterial cells, why water improves its effectiveness, and what the additional ingredients in sanitizer actually do.
Scott Phillips, CEO of StarFish Medical, sits down with Peter van der Velden, Managing General Partner at Lumira Ventures, to explore the strategic thinking behind major MedTech transactions and investments.
Computer vision technologies such as convolutional neural networks and vision transformers are transforming how AI analyzes medical images, each offering distinct advantages depending on the application and computing environment.
Ariana and Mark explore how prototype strategy helps teams reduce technical risk and accelerate progress.